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Abstract
In the past few decades, a worldwide increase in the incidence of fungal infec-
tions has been observed as well as rise in the resistance of some species of fungi to 
different fungicidal used in medicinal practice. Besides, fungi are the one of the 
most neglected pathogens as demonstrated by the fact that the amphotericin B 
and other sold treatments are still used as gold standard as antifungal therapy. The 
majority of used antifungal treatments have various drawbacks in terms of toxicity, 
efficacy as well as cost and their frequent use has also led to the emergence of resis-
tant strains. Hence, there is a great demand for developing an antifungal belonging 
to a wide range of structural classes, selectively acting on new targets with least side 
effects. Natural products, either as pure phytocompounds or as standardized plant 
extracts, provide unlimited opportunities for new drug lads because of their having 
normally matchless chemical diversity. Present chapter focused on the work done in 
the field of antifungal activities of various plant components and novel approaches 
which will be the future prospective for the new drug discoveries and providing 
better antifungal therapy.
Keywords: antifungal, phytocompounds, fungicidal, antifungal therapy,  
fungal infections
1. Introduction to fungal disease
Fungal infections are one of the most deadly infections accounting in excess of 
1.5 million deaths annually worldwide. The major reason that makes fungal infec-
tions more life threatening because they are been neglected by the society. Though 
in last 20 years there are many developments in the diagnosis and treatment of 
fungal disease but still majority of population are devoid of the benefits of these 
developments [1]. Among all the fungal diseases, infection of skin hold the 4th 
position and it accounts for the majority of death also [2].
Plant kingdom has always been a hub for many natural compounds with novel 
structure and this keep the investigators interested in doing research about many 
plants species till today. Results of new researchers showed that plants are enrich of 
many bioactive secondary metabolites such as saponins, alkaloids and terpenoids 
which characterized by antifungal property. Depending on that, these plants can be 
considered as a potent future source for anti-fungal drugs [3]. When recent scenario 
regarding fungal diseases and antifungal drugs are taken into consideration it 
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has been seen that the development of resistance of fungus towards the presently 
used antifungal drugs has increased [4–11]. With the challenges like morbidity 
and mortality there always lies difficulty in antifungal treatment for patients 
receiving therapy for AIDS, diabetes, chemotherapy or organ transplant as some 
of the molecular processes of fungus are similar to humans, so toxicity to fungal 
cells could affect human cells too [12]. In the last 30 years few drugs have made an 
impact in the treatment of fungal infection as shown in (Table 1), one of them is 
amphotericin B which is among the few fungicidal drugs present antifungal therapy 
has but it also showed several critical side effects (Table 2) [13]. In addition to this, 
during the period between late of 1980s and the beginning of 1990s emergence of 
Imidazoles and Triazoles was seen. These classes of drugs were efficient in inhibit-
ing processes associated with fungal cells. The major drawback associated with 
them was relapse of infection and resistance developed by the fungus towards them 
[14]. Therefore, it become an oblige for the research to discover and produce a new, 
efficient, and safe anti-fungal treatments from new sources like plants. Therefore 
current chapter attempts to elaborate the current scenario about the important 
plants and their antifungal derivatives that can be future prospective to work on for 
development of more potent antifungal drugs.
There are around 2 million of fungal species found in the whole world but only 
600 of them cause infection. The major species that are mostly involved in causing 
infection are Cryptococcus, Candida, Trichophyton and Aspergillus. All the fungal 
infections which affects human, that are prevailing in the world can be grouped into five 
types. The types are as follows:
1. Invasive fungal infections: examples are cryptococcal meningitis, Candida 
bloodstream infection, invasive aspergillosis, Pneumocystis pneumonia
2. Chronic lung or deep tissue infection: under this type example is chronic pulmo-
nary aspergillosis
3. Allergic fungal disease: examples are allergic bronchopulmonary aspergillosis 
also known as ABPA and severe asthma with fungal sensitization (SAFS)
S. No Class Drugs Uses
1. Azole 
antifungals
Clotrimazole, Econazole, 
Isoconazole, Miconazole, 
Ketoconazole, Itraconazole
Topical fungal infections, Candidiasis, 
aspergillus and candida infections, 
vaginal yeast infections
2. Echinocandins Caspofungin, Micafungin Esophageal Candidiasis, Salvage therapy
4. Polyenes Amphotericin B, Nystatin Systemic mycosis, superficial mycosis
5. Phenolic 
cyclohexane
Griseofulvin Dermatophytic infections
6. Synthetic 
pyrimidines
Flucytosine Cryptococcosis, severe invasive 
aspergillosis, cryptococcal meningitis 
treated along with other antifungals
7. Morpholines Amorolfine Topical fungal infections
8. Pyridines Buthiobate, Pyrifenox Dermatophytic infections, Tinea 
conditions
9. Phthalimides Captan Invasive dermatophytic conditions and 
candida infections
Table 1. 
The synthetic drugs available in market for treatment of fungal diseases are – [15].
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4. Mucosal infection: oral and esophageal candidiasis, Candida vaginitis are ex-
amples of this group.
5. Skin, hair and nail infection: examples of this kind of infections are athlete’s 
foot tinea capitis and onychomycosis [16].
2. Plants having antifungal activity
The epidemiological data suggest that the incidence and prevalence of serious 
mycoses continues to be a public health problem. The increased use of antifungal 
agents has resulted in the development of resistance to these drugs. The spread of 
multidrug-resistant strains of fungus and the reduced number of drugs available 
make it necessary to discover new classes of antifungals from natural products 
S. No Side effects Drugs
1. Non-melanoma skin cancer 
prolonged therapy
Voriconazole
2. Fever, Chills Isavuconazole, Ketoconazole, Voriconazole, Flucytosine, 
Anidulafungin, Caspofungin
3. Rash Flucytosine, Fluconazole, Ketoconazole, Clotrimazole, 
Voriconazole
4. Nausea, vomiting Isavuconazole, Itraconazole, Flucytosine, Fluconazole, 
Ketoconazole, Clotrimazole, Voriconazole
5. Abdominal pain Flucytosine, Ketoconazole, Isavuconazole, Voriconazole
6. Anemia Amphotericin B, Caspofungin, Flucytosine
7. Leukopenia, Thrombocytopenia Flucytosine, Fluconazole
8. Decreased renal function Amphotericin B, Caspofungin, Voriconazole
9. Headache Flucytosine, Fluconazole, Ketoconazole, Isavuconazole, 
Voriconazole, Caspofungin
10. Dark urine, clay-colored stools, 
jaundice
Anidulafungin C, Micafungin
Table 2. 
Adverse side effects of different antifungals.
S. No. Botanical name Family Parts 
used
Chemical 
classes
Microorganism 
tested
1. Eugenia uniflora Myrtaceae Leaves Sesquiterpenes, 
Monoterpene, 
hydrocarbons
C. albicans, C. 
dubliniensis, C. 
glabrata, C. krusei [17]
2. Psidium guajava Myrtaceae Leaves Methanolic 
extract
C. albicans, C. 
dubliniensis, C. 
glabrata, C. krusei [17]
3. Curcuma longa Zingiberaceae Rhizome Turmeric oil C. albicans, C. 
dubliniensis, C. 
glabrata, C. krusei [17]
4. Piptadenia 
colubrina
Mimosaceae Stem bark — C. albicans, C. 
dubliniensis, C. 
glabrata [17]
5. Schinus 
terebinthifolius
Anacardiaceae Stem bark Extract C. albicans, C. 
dubliniensis [17]
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S. No. Botanical name Family Parts 
used
Chemical 
classes
Microorganism 
tested
6. Persea americana Lauraceae Leaves Chromene C. albicans C. 
dubliniensis C. 
glabrata, C. krusei [17]
7. Parapiptadenia 
rigida
Fabaceae Stem bark Pyrrolidine 
amide
C. albicans [17]
8. Ajania fruticulosa Asteraceae Fruits Guaianolides Candida albicans, C. 
glabrata A.  
fumigatus [17]
9. Alibertia 
macrophylla
Rubiaceae Leaves Extract Cladosporium 
sphaerospermum; C. 
cladosporioides; A. 
niger; Colletotrichum 
gloeosporioides [17]
10. Aniba panurensis Lauraceae Whole 
plant
— C. albicans [17]
11. Aquilegia vulgaris Ranunculaceae Leaves 
and stems
Bis (benzyl) A. niger [17]
12. Mimosa tenuiflora Mimosaceae Stem bark Sesquiterpene 
lactone
C. albicans, C. 
dubliniensis, C. 
glabrata, C. krusei [17]
13. P. regnellii Piperaceae Leaves Extract Trichophyton rubrum, 
Trichophyton 
mentagrophytes, 
Microsporum canis [18]
14. Rubia tinctorum Rubiaceae Root Triterpene A. niger, Alternaria 
alternaria, P. 
verrucosum, Mucor 
mucedo [19]
15. Tithonia 
diversifolia
Asteraceae Whole 
plant
Contained 
saponins, 
Polyphenols
Microbotryum 
violaceum, Chlorella 
fusca [20]
16. Vernonanthura 
tweedieana
Asteraceae Root Extracts T. mentagrophytes [21]
17. Zingiber officinale Zingiberaceae Rhizomes Steroidal 
saponin
P. oryzae [22]
18. Datura metel Solanaceae Whole 
plant
Diterpenoid, 
Alkaloids
C. albicans, C. 
tropicalis [23]
19. Lupinus albus Leguminosae Leaf 
surface
— T. mentagrophytes [24]
20. Ecballium 
elaterium
Cucurbitaceae Fruit Extract Boitylis cinerea [25]
21. Cassia tora Leguminosae Seeds Anthraquinone Botrytis cinerea, 
Erysiphe graminis, 
Phytophthora infestans, 
Puccinia recondita, 
Pyricularia grisea [26]
22. Chamaecyparis 
pisifera
Cupressaceae Leaves 
and Twigs
Isoflavone P. oryzae [27]
23. Prunus yedoensis Rosaceae Leaves Diterpenes C. herbarum [28]
Table 3. 
List of plants having antifungal activity against pathogenic fungi.
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including medicinal plants. Medicinal plants have also been reported in traditional 
systems of medicine for the treatment of both human and animal mycoses, and are 
considered to be a valuable source for the discovery of new antifungal drugs. Many 
books have also reported and recorded the use of medicinal plants in the traditional 
system of medicine. Therefore, we have focused here mainly on the antifungal 
plants and their use against pathogenic fungi. The antifungal activity associated 
plants are illustrated in (Table 3).
3. Phytochemicals and their antifungal activity
Plants and their biologically active chemical constituents, sometimes called 
secondary metabolites or bioactives, present numerous opportunities for the 
improvement of livestock production by inclusion in the diet. Several papers and 
reviews have been published on the occurrence of antifungal compounds in plant. 
However, literature and systematic reviews on the natural products as an alterna-
tive to antifungal drugs are still scanty. The distribution of antifungal compounds 
can be defined either on the basis of their taxonomic distribution or on the basis of 
their chemical classes. Table 4 shows the antifungal natural products belonging to 
S. No Plants Plant part Phytochemicals
1 Aegle marmelos Leaves Essential oils
2 Alpinia galangal Seeds Diterpenes
3 Ananas comosus Leaves Protein
4 Blumea balsamifera Leaves Flavonoid luteolin
5 Camptotheca acuminate Leaves Flavonoid
6 Capsicum frutescens Whole plant Triterpene saponin
7 Cassia tora Whole plant Emodin, physcion and rhein
8 Datura metel Whole plant Alkaloid
9 Euonymus europaeus Leaves Protein
10 Haloxylon salicornium Aerial part Alkaloid
11 Juniperus communis Leaves Essential oil
12 Khaya ivorensis Stem bark Triterpenes
13 Lycium chinense Root bark Phenolic compounds
14 Musa acuminate Banana Protein
15 Ocimum gratissimum Bark Essential oil
16 Pinus pinaster Leaves Pinosylvin
17 Polygonum punctatum Whole plant Sesquiterpene
18 Smilax medica Root Saponins
19 Solanum tuberosum Tubers Protein
20 Thymus vulgaris Whole plant Essential oil
21 Trachyspermum ammi Leaves, flowers Essential oil
22 Trigonella graecum Whole plants Peptides
23 Zingiber officinalis Rhizome Protein
Table 4. 
List of plant components having antifungal property [29].
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all major classes of secondary metabolites such as phenolics, alkaloids, terpenoids, 
saponins, flavonoids, proteins, and peptides, etc.
4. Novel approaches for antifungal plant components and their extracts
Novel drug delivery system has shown tremendous potential to deliver herbal 
drugs in the form of microcapsules, implants, nanoparticles micro particles sus-
tained release tablets or extended release forms. Many herbal drugs using novel 
drug delivery system has made a mark in the market and few of them are in the 
developmental stage in the laboratory [30].
Active herbal components such as curcumin, digoxin, atropine, bromelain can be 
promising prospects for treatment of conditions like cancer or inflammation [31].
The popularity experienced by novel drug delivery system is due to its ability 
to deliver the herbal drugs in a better way providing enhanced therapeutic efficacy 
with lower toxicity [32]. In addition to this it also counteract the limitations of 
lower absorption and lack of specificity experienced by the available formulation of 
drugs. Advantages of novel drug delivery system over the presently available drug 
therapy is that it is specific, has rapid onset of action with faster absorption due to 
enhanced surface area and lastly nanoparticles provides better penetration in Blood 
Brain Barrier (BBB) [33].
For any herbal drugs to show expected therapeutic efficacy optimum amount 
of active constituent must reach the target tissues. Herbal drugs are prone to be 
degraded by first pass metabolism of by the pH difference of GIT. Various novel 
drug delivery systems such as nanoparticles, nanoemulsions, phytosomes, trans-
ferosomes and liposomes by passes all the hurdles of acidic pH as well as first pass 
metabolism to carry optimum amount of drugs to target tissues. Being smaller in 
size nano carriers also provides rapid onset of actions [34].
For delivery of drug by using novel drug delivery system, herbal drugs present 
themselves as potential candidate because of following reasons:
• The side effects that are seen with other drugs are absent with natural 
compounds.
• Natural compounds shows synergistic effect when they contain multifunc-
tional molecules.
• Natural compounds have traditional backing for their action and safety poten-
tial whereas modern medicines are more toxic even if they are experimentally 
proven for their action [35].
4.1 Novel carrier systems used to treat different fungal infections
The major benefit provided by novel drug delivery system is to elicit better 
therapeutic response with minimum doses. Types of carriers used for herbal drug 
delivery and synthetic drugs are as follows:
4.1.1 Phytosomes
The name came from two words “Phyto” and “some” which means plant and 
cell-like respectively. Phytosomes contains lipid soluble complex of phospholipids 
and phyto-constituents. Some literatures also referred Phytosomes as ribosome 
[36]. Green tea phytosomes, Ginkgo biloba phytosomes, Centella phytosomes, 
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Meriva phytosome, Zanthalene phytosomes, Sericoside phytosomes are some 
examples of phytosomes which are recently developed and characterized for differ-
ent ailments. Among all of them Zanthalene phytosomes are prepared especially for 
the treatment of fungal disease.
Advantages of Phytosomes
• Phytosomes are not degraded by bacteria or digestive secretion of guts.
• It has better stability because of the formation of bonds chemically connecting 
phytoconstituents and phosphatidylcholine molecules.
• Phytosomes delivers herbal drug to the respective target tissues [37].
• It shows greater therapeutic benefit due to better absorption of lipid insoluble 
polar phytoconstituents in turn shows better bioavailability [38].
4.1.2 Liposomes
Liposomes contain microscopic vesicles made up of lipid bilayer arranged in 
concentric fashion and the separation is filled with aqueous medium. Lipophilic 
substances are inserted into the lipid bilayer whereas aqueous compartment 
traps hydrophilic substance. Liposomes show better bioavailability, stability and 
enhanced pharmacokinetic property [39]. There are various herbal and synthetic 
liposomes are prepared for the effective treatment of different skin diseases. In 
2017, a herbal liposomal gel containing ketoconazole and neem extract was devel-
oped for the effective treatment of seborrheic dermatitis against Aspergillus niger 
and Candida albicans. The results indicated that developed liposomal gel have great 
potential and showed synergetic effect for the treatment.
Advantages of liposomes
• Liposome formulation is better options for producing sustained release formu-
lations as it enhances drug solubility.
• It is easy to load phytoconstituents of any chemical nature whether it is hydro-
philic, amphiphilic or lipophilic [40].
4.1.3 Nanoparticles
This carrier system has particle size within the range between 1 and 100 nm. The 
particles which are of nano size are made up of polymer of synthetic or semisyn-
thetic origin. Nanoparticles are microencapsulated to protect them from any kind of 
losses. Nanoparticles were made to encounter the problem of solubility and toxicity 
associated with triptolide [41].
Advantages of herbal nanoparticle delivery system:
• Nanoparticles having smaller size shows better dissolution in turn enhances 
solubility of dosage form and it also delivers drug with specificity thereby 
enhancing the efficacy [42].
4.1.4 Microemulsions and nanoemulsion
These are emulsions of O/W type and the particle size of the particulate is of 
micron. In this drug delivery system inner phase stores the drugs and because of its 
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contact with tissue directly drug release is slow. As per few reports oil of Pterodon 
emarginatus are considered to have property to enhance anti-inflammatory activity 
[43]. Formulation, development and evaluation of microemulsion gel of hydroal-
coholic extract of Quercus infectoria in the treatment of different skin ailments was 
successfully prepared. Tannins which are prime constituent of galls can be effec-
tively treat different skin conditions.
4.1.5 Microsphere
This drug delivery system have matrix and the drug is dispersed in a polymer 
which are present inside this matrix. Particle size that can be used is in between 1 
and 300 μm. The release of drug is dependent on the dissolution and degradation 
rate of the said matrix. Release of drug occurs according to first order kinetic. 
For example, development and evaluation of floating microspheres of curcumin 
prepared by emulsion solvent diffusion method for treatment of onychomycosis. 
The result shows improved absorption kinetics of curcumin.
Advantages of microsphere formulations
• The major advantage of this kind of formulation is that it taken orally or 
parentally and their site of release can also be targeted [44].
4.1.6 Niosomes
Niosomes are similar as liposomes bjt are far more stable than liposomes. 
Niosomes are made up of surfactant like dialkyl polyglycerol which is noninonic in 
nature and are able encapsulate variety of drugs. Niosomes are more economical 
than liposomes [32]. Chitosan niosomal gel, miconazole niosomes are prepared as 
an effective nanocarrier against both dermatophytes and yeasts.
4.2 Transdermal drug delivery system
In this system of drug delivery, patches encapsulating drugs are prepared and 
are placed on the skin. Through the skin drug enters into the blood vessels. This 
system is beneficial when the required effect of oral therapy was not found to be 
up to the mark. Patches of antismoking and anti-motion sickness are available in 
market [45].
Advantages of transdermal drug delivery
• The transdermal delivery system has advantages such as it provides enhanced 
bioavailability and provides a better alternative of dosage form for unconscious 
or vomiting patients [46].
4.2.1 Ethosomes
Ethosomes are composed of phospholipids and ethanol and are in the form 
of sac. Ethanol present in ethosomes acts as permeability enhancer. Ethosomes 
are found in the form of cream and gel for better patient compliance [47]. Now 
a days, Transethosomes and Nanoethosomes used most widely which are the 
advanced type of ethosomes having edge activator in it. These advanced novel 
carrier system is much better than conventional novel carriers like transfero-
somes and liposomes [48]. Clotrimazole, Itraconazole, Miconazole are synthetic 
drugs which are prepared and evaluated successfully for the treatment of 
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dermatophytosis or ringworm. Tridax procumbens and Galinsoga parvifolia are 
two herbs used into ethosomal gel against Trichophyton species.
Advantages of Ethosome
• Ethosomes can entrap all type of drugs and have better skin permeability [46].
4.2.2 Transferosomes
Transferosomes contains phospholipids sac which behaves as carrier for deliv-
ery of drug through the skin. As Transferosomes are flexible in nature they cross 
the skin through the intracellular space found within the skin. Transferosomes of 
Colchicines shows lesser side effect than its oral form [49].
Advantages of Transferosomes:
• Transferosomes being flexible can pass through narrow openings of skin.
• It shows high efficiency of entrapment which may increase up to 90% in case 
of lipophilic drug [50].
4.2.2.1 Complexation
The problem associated with herbal drug formulation is their solubility. To 
counter this solubility problem, complex formation is done which gives particulates 
with well-defined stoichiometry. Few commonly used complexing agents are EDTA 
and cyclodextrin [51].
Drugs/Plant 
components
Novel carriers Indication Microorganism 
tested
Essential oil (Bidens 
tripartite)
Microemulsion gel Candidiasis Candida albicans
Curcumin Phytosome Onychomycosis Yeast sp.
Clotrimazole, Econazole 
nitrate, Fluconazole
Micelles Superficial fungal infection Trichophyton sp.
Miconazole Solid lipid 
nanoparticles and 
nanostructured 
lipid carriers
Candidiasis Candida albicans
Fluconazole, 
Ketoconazole, 
Itraconazole, 
Voriconazole, Econazole
Microemulsion Tinea corporis, Tinea circinata, 
Tinea pedis
Candida albicans
Amphotericin B Microemulsion Invasive fungal infection Trichophyton 
rubrum
Griseofulvin Microemulsion gel Dermatophytosis Trichophyton sp.
Terbinafine Hcl Niosomes Fungal infection Aspergillus niger
Griseofulvin, 
Amphotericin B
Transferosomes Dermatophytosis Trichophyton 
rubrum
Clotrimazole, Econazole Ethosomes Localized skin fungal infection Candida sp.
Table 5. 
List of some novel carriers for antifungal plant components and synthetic drugs [55].
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4.2.2.2 Hydrogels
The hydrogel are three dimensional structures with cross linking of polymers. 
As name suggest hydrogels are hydrophilic in nature. Hydrogels can be designed 
into different forms according to the needs. The form can be of slabs, films and 
nanoparticle coating [52]. Hydrogels have the potential to bind both herbal as well 
as synthetic drug, this ability can be treated as avenue for further research [53]. 
There are many marketed formulation of novel drug delivery available in the mar-
ket [46, 54] Here are list of some novel carriers used with their plant components or 
synthetic drugs combinations for different fungal infections (Table 5).
5. Conclusion
The last 20 years has shown an increase in number of fungal infection. Currently 
used drugs in treatment of fungal infection are having many side effects, and 
development of resistance is very common against these drugs. Plants have been 
considered as traditional source of antifungal medicines for past many years. Plant 
bioactive with antifungal activity can be considered as an option for development 
of new and improved alternative formulations in antifungal therapy. Development 
of improved formulations with plant phytcompounds is the need of the hour for 
efficient treatment of fungal diseases. Further research on this field can provide us 
with increased number of options in treatment of fungal diseases that will give the 
patients with a better quality of life.
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